HDAC9 and rheumatoid arthritis: Accordingly, Etinostat (MS275), a class I HDAC inhibitor, selectively affecting HDAC1-3, showed to decrease cell proliferation and secretion of the pro-inflammatory cytokines IL-6 and IL-18 and nitric oxide in cultured human fibroblastic cells from RA patients (119).